These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15501718)

  • 1. Quality: an old solution to new discovery dilemmas?
    Volsen SG; Kent JM; Masson M
    Drug Discov Today; 2004 Nov; 9(21):903-5. PubMed ID: 15501718
    [No Abstract]   [Full Text] [Related]  

  • 2. [Guidelines for introducing new drugs for medical use in Poland and control of their quality].
    Danysz A
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1673-4. PubMed ID: 6522321
    [No Abstract]   [Full Text] [Related]  

  • 3. A practical approach to supplier quality improvement.
    O'Riordan L
    J Parenter Sci Technol; 1991; 45(1):29-40. PubMed ID: 2007967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Standards of good production. Problems of sampling].
    Fontani F; Sekules G; Zanotti Gerosa A
    Boll Chim Farm; 1975 Feb; 114(2):57-69. PubMed ID: 1203102
    [No Abstract]   [Full Text] [Related]  

  • 5. Expectations for process validation: industry perspectives.
    Francis R
    Dev Biol (Basel); 2003; 113():9-14. PubMed ID: 14620847
    [No Abstract]   [Full Text] [Related]  

  • 6. The other side of process validation.
    Agalloco JP
    J Parenter Sci Technol; 1986; 40(6):251-2. PubMed ID: 3819977
    [No Abstract]   [Full Text] [Related]  

  • 7. [Standards of good production. Human and technical aspects].
    Rocchi B
    Boll Chim Farm; 1975 Jan; 114(1):3-9. PubMed ID: 1203097
    [No Abstract]   [Full Text] [Related]  

  • 8. [Maintaining standards of good compounding (N.B.F.)].
    Castoldi B; Fumagalli A; Mazzoldi G
    Boll Chim Farm; 1978 Dec; 117(12):689-99. PubMed ID: 752351
    [No Abstract]   [Full Text] [Related]  

  • 9. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2008; (948):1-138. PubMed ID: 18557474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [For the increase of qualification of engineering cadres for the chemical and pharmaceutical industry].
    Blazek J
    Cesk Farm; 1974 Dec; 23(10):397-9. PubMed ID: 4455399
    [No Abstract]   [Full Text] [Related]  

  • 11. A new approach to quality training.
    Betts WA
    J Parenter Sci Technol; 1981; 35(5):248-50. PubMed ID: 7299602
    [No Abstract]   [Full Text] [Related]  

  • 12. [Standards of good manufacturing. Autoinspection].
    Anitco G; Guiggi A; Mazzoldi G; Paravidino C; Vianello GS
    Boll Chim Farm; 1975 Apr; 114(4):190-200. PubMed ID: 1131322
    [No Abstract]   [Full Text] [Related]  

  • 13. Emerging Technology as a Key Enabler for Modernizing Pharmaceutical Manufacturing.
    Lee SL; Brorson K
    PDA J Pharm Sci Technol; 2017; 71(2):66-67. PubMed ID: 28396563
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceutical quality: big pharma also at fault.
    Prescrire Int; 2012 Feb; 21(124):54. PubMed ID: 22413728
    [No Abstract]   [Full Text] [Related]  

  • 15. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-first report.
    World Health Organization
    World Health Organ Tech Rep Ser; 2007; (943):1-156. PubMed ID: 17621973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strengthening drug manufacturing practices.
    Hecht A
    FDA Consum; 1976; 10(6):12-4. PubMed ID: 829227
    [No Abstract]   [Full Text] [Related]  

  • 17. [Quality control changes in release controller system].
    Smewing J
    Boll Chim Farm; 2001; 140(3):192-4. PubMed ID: 11486613
    [No Abstract]   [Full Text] [Related]  

  • 18. Certification Scheme on the Quality of Pharmaceutical Products moving in International Commerce.
    WHO Chron; 1977 Dec; 31(12):suppl 1-19. PubMed ID: 602166
    [No Abstract]   [Full Text] [Related]  

  • 19. Validation, risk-benefit analysis.
    Kieffer RG
    PDA J Pharm Sci Technol; 1995; 49(5):249-52. PubMed ID: 7489200
    [No Abstract]   [Full Text] [Related]  

  • 20. PDA Points to Consider: Technical Product Lifecycle Management. Pharmaceutical Quality System Effectiveness for Managing Post-approval Changes.
    ; Ramnarine E; Busse U; Colao M; Edwards J; O'Donnell K; Jornitz M; Munk M; Seymour M; Simianu M; Skeens L; Vinther A
    PDA J Pharm Sci Technol; 2017; 71(3):252-258. PubMed ID: 28196929
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.